Explore PEG-MGF dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator data.
PEG-MGF has a reported half-life of ~2 days. The pharmacokinetic reference models an interval of twice weekly; this is not a measured community cadence or a dosing recommendation. Pegylation greatly extends MGF's half-life from minutes to roughly two days, so a twice-weekly cadence keeps levels reasonably stable rather than requiring daily dosing. Pharmacokinetic source: Pre-clinical PEG-MGF pharmacokinetic estimates. It is catalogued under Other Peptides on WPA.
13 PEG-MGF reconstitution calculations have been logged by the WPA community.
This is the lifetime header population. Each chart and its associated analysis below use their own selected period and denominator; frequency responses are a separate cohort.
These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.